GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Other Long Term Assets

Cytophage Technologies (TSXV:CYTO) Other Long Term Assets : C$-0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Other Long Term Assets?

Cytophage Technologies's other long-term assets for the quarter that ended in Mar. 2024 was C$-0.00 Mil.

Cytophage Technologies's quarterly other long-term assets declined from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil) but then stayed the same from Dec. 2023 (C$0.00 Mil) to Mar. 2024 (C$-0.00 Mil).

Cytophage Technologies's annual other long-term assets increased from Dec. 2021 (C$-0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then stayed the same from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).


Cytophage Technologies Other Long Term Assets Historical Data

The historical data trend for Cytophage Technologies's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Other Long Term Assets Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Other Long Term Assets
- - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial - - - - -

Cytophage Technologies Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Cytophage Technologies (TSXV:CYTO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies (TSXV:CYTO) Headlines

From GuruFocus

Altamira Therapeutics Provides Business Update

By Stock market mentor Stock market mentor 01-27-2023

Altamira Therapeutics Announces Reverse Stock Split

By Value_Insider Value_Insider 10-24-2022